Biopharmaceutical company GW Pharmaceuticals plc (NASDAQ: GWPH) revealed Tuesday that its revenue for the third quarter hit $137.1 million, up by 51% year-over-year. For the first nine months ... Read More
Dutch researchers plan a large double-blinded, randomized placebo-controlled crossover study on more than 300 people in The Netherlands using cannabis products This study will give ... Read More